Journal article icon

Journal article

SOX9 in organogenesis: shared and unique transcriptional functions

Abstract:
SRY-box transcription factor 9 (SOX9) has been reported to be overexpressed in a wide variety of gastrointestinal malignancies. While its role has been studied in gastric cancer (GC), the results remain conflicting. This study aimed to evaluate the relationship between SOX9 immunohistochemistry results and the pathological and clinical characteristics of gastric adenocarcinoma, assessing its potential as a prognostic marker. Gastric tissue samples from 150 patients with gastric cancer were included in the study. Tissue sections were stained using an anti-SOX9 antibody, and relevant data were retrospectively collected from digital records. Immunostaining results were scored based on the proportion and intensity of stained nuclei throughout the tumor. A final immunostaining score was calculated by multiplying the SOX9 intensity score by the proportion score. Strong SOX9 nuclear staining was observed in 68 patients (45.3%), while moderate staining was seen in 60 patients (40%). SOX9 nuclear staining was absent in three patients (2%). A final SOX9 immunostaining score of ≥10, classified as high expression, was identified in 60 patients (40%). Patients with higher SOX9 expression or strong intensity scores exhibited significantly larger tumor sizes, higher rates of perineural and vascular invasion, more advanced T or lymph node staging, and greater likelihoods of lymphatic or distant metastases compared to those with lower SOX9 expression or intensity scores (all P < 0.05). These findings suggest that SOX9 staining intensity and expression are associated with increased tumor malignancy and disease progression. Therefore, SOX9 may serve as a prognostic pathological indicator in GC patients
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1007/s00018-022-04543-4

Authors

More by this author
Role:
Author
ORCID:
0000-0003-0882-7216
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-4882-3626
More by this author
Role:
Author
ORCID:
0000-0003-3710-4797
More by this author
Role:
Author
ORCID:
0000-0002-2405-1262


Publisher:
Springer
Journal:
Cellular and Molecular Life Sciences More from this journal
Volume:
79
Issue:
10
Pages:
522-522
Article number:
522
Publication date:
2022-09-17
DOI:
EISSN:
1420-9071
ISSN:
1420-682X


Language:
English
Keywords:
Pubs id:
2391873
Local pid:
pubs:2391873
Source identifiers:
W4296164586
Deposit date:
2026-03-20
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP